<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo>, infantile, neurological, cutaneous, and articular (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CINCA</z:e>) syndrome, also known as <z:hpo ids='HP_0003623'>neonatal-onset</z:hpo> multisystem <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e>), is a rare <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">inherited disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It is characterized by a persistent <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> with <z:hpo ids='HP_0003674'>onset</z:hpo> during the neonatal period, neurological and ocular manifestations, and articular involvement with abnormal ossification </plain></SENT>
<SENT sid="2" pm="."><plain>Mutations within the CIAS1 gene are found in up to 60% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CINCA</z:e> cases, but the exact underlying pathogenetic mechanisms causing this disorder are still unclear </plain></SENT>
<SENT sid="3" pm="."><plain>Although the interleukin-1 (IL-1) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> anakinra (rHuIL-1Ra) has recently been reported to be effective, no formal recommended treatment protocols exist thus far </plain></SENT>
<SENT sid="4" pm="."><plain>Herein, we describe a 17-year-old girl with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CINCA</z:e> for whom numerous medication trials had been unsuccessful </plain></SENT>
<SENT sid="5" pm="."><plain>After the introduction of thalidomide, the symptoms of <z:hpo ids='HP_0003040'>arthropathy</z:hpo> improved dramatically even months after the medication was discontinued by the patient </plain></SENT>
<SENT sid="6" pm="."><plain>We propose that thalidomide can be beneficial in select patients with <z:e sem="disease" ids="C0409818" disease_type="Disease or Syndrome" abbrv="CINCA">CINCA syndrome</z:e> </plain></SENT>
</text></document>